With early signs indicating the COVID-19 caseload is poised to grow in the weeks ahead, Health Canada is actively reviewing three new vaccines specifically designed to target an Omicron subvariant of the virus.

The department told CBC News Monday that new mRNA vaccines from Pfizer and Moderna and a non-mRNA product from Novavax have been part of a months-long review process and supplies could start to roll out in the fall.

That timeline is similar to what is planned south of the border. The U.S. is poised to release an updated COVID booster in late September once regulators there sign off on the new